SBFM Q4 2020 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

Q4 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$28,013+165.4% YoY

Gross Profit

$17,55062.6% margin

Operating Income

-$343,000-1224.4% margin

Net Income

-$1M-3869.6% margin

EPS (Diluted)

$-6.43

QoQ Revenue Growth

+63.3%

Cash Flow

Operating Cash Flow

-$423,672

Free Cash Flow

-$424,063

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1M

Total Liabilities

$2M

Stockholders' Equity

-$954,837

Cash & Equivalents

$989,888

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28,013	$10,556	+165.4%
Gross Profit	$17,550	$6,371	+175.5%
Operating Income	-$343,000	-$250,590	-36.9%
Net Income	-$1M	-$396,618	-173.3%